RETRACTION: MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2 (Retraction of Vol 44, Pg 1785, 2017)

被引:0
|
作者
Lv, Zhi-Dong
Yang, Dong-Xia
Liu, Xiang-Ping
Jin, Li-Ying
Wang, Xin-Gang
Yang, Zhao-Chuan
Liu, Dong
Zhao, Jiao-Jiao
Kong, Bin
Li, Fu-Nian
Wang, Hai-Bo
机构
关键词
D O I
10.33594/000000637
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:199 / 199
页数:1
相关论文
共 50 条
  • [1] RETRACTED: MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2 (Retracted article. See vol. 57, pg. 199, 2023)
    Lv, Zhi-Dong
    Yang, Dong-Xia
    Liu, Xiang-Ping
    Jin, Li-Ying
    Wang, Xin-Gang
    Yang, Zhao-Chuan
    Liu, Dong
    Zhao, Jiao-Jiao
    Kong, Bin
    Li, Fu-Nian
    Wang, Hai-Bo
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 44 (05) : 1785 - 1795
  • [2] RETRACTION: miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer (Retraction of Vol 20, art no 864, 2016)
    Lv, Zhi-Dong
    Kong, Bin
    Liu, Xiang-Ping
    Jin, Li-Ying
    Dong, Qian
    Li, Fu-Nian
    Wang, Hai-Bo
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (08)
  • [3] RETRACTION: Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer (Retraction of Vol 20, Pg 1640, 2016)
    Lv, Zhi-Dong
    Yang, Zhao-Chuan
    Liu, Xiang-Ping
    Jin, Li-Ying
    Dong, Qian
    Qu, Hui-Li
    Li, Fu-Nian
    Kong, Bin
    Sun, Jiao
    Zhao, Jiao-Jiao
    Wang, Hai-Bo
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (08)
  • [4] miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer
    Lv, Zhi-Dong
    Kong, Bin
    Liu, Xiang-Ping
    Jin, Li-Ying
    Dong, Qian
    Li, Fu-Nian
    Wang, Hai-Bo
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2016, 20 (05) : 864 - 873
  • [5] RETRACTION: Silencing of Prrx2 Inhibits the Invasion and Metastasis of Breast Cancer both In Vitro and In Vivo by Reversing Epithelial- Mesenchymal Transition (Retraction of Vol 42, Pg 1847, 2017)
    Lv, Zhi-Dong
    Wang, Hai-Bo
    Liu, Xiang-Ping
    Jin, Li-Ying
    Shen, Ruo-Wu
    Wang, Xin-Gang
    Bin Kong
    Qu, Hui-Li
    Li, Fu-Nian
    Yang, Qi-Feng
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2023, 57 (06) : 542 - 542
  • [6] MiR-199a-5p is a biomarker for and regulator of epithelial-mesenchymal transition in triple-negative breast cancer patients
    Shin, Vivian Y.
    Siu, Man T.
    Ho, John C.
    Kwong, Ava
    CANCER RESEARCH, 2014, 74 (19)
  • [7] Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer
    Lv, Zhi-Dong
    Yang, Zhao-Chuan
    Liu, Xiang-Ping
    Jin, Li-Ying
    Dong, Qian
    Qu, Hui-Li
    Li, Fu-Nian
    Kong, Bin
    Sun, Jiao
    Zhao, Jiao-Jiao
    Wang, Hai-Bo
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2016, 20 (09) : 1640 - 1650
  • [8] RETRACTION: Overexpressed miR-106b-5p promotes epithelial-mesenchymal transition in endometriosis by targeting PTEN (Retraction of Vol 113, Pg 62, 2022)
    Hu, Fen
    Wang, Yonglian
    Wu, Xueqing
    Liu, Shan
    Ren, Haiying
    Zhou, Wenhui
    REPRODUCTIVE TOXICOLOGY, 2023, 118
  • [9] RETRACTION: miR-484 suppresses proliferation and epithelial-mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells (Retraction of Vol 17, art no 36, 2017)
    Hu, Yang
    Xie, Hong
    Liu, Yankun
    Liu, Weiying
    Liu, Min
    Tang, Hua
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [10] miR-30a inhibits epithelial-mesenchymal transition and metastasis in triple-negative breast cancer by targeting ROR1
    Wang, Xin
    Qiu, Huisi
    Tang, Ruiming
    Song, Huisheng
    Pan, Huilin
    Feng, Zhengfu
    Chen, Longhua
    ONCOLOGY REPORTS, 2018, 39 (06) : 2635 - 2643